Cargando…

2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease

OBJECTIVES/SPECIFIC AIMS: Nonalcoholic fatty liver disease (NAFLD) affects 1 in 3 Americans and can exist in 2 histological subtypes: simple hepatic steatosis (SHS) and nonalcoholic steatohepatitis (NASH), a clinically aggressive variant. Fatigue is the most common complaint in patients with NAFLD b...

Descripción completa

Detalles Bibliográficos
Autores principales: Canada, Justin M., Billingsly, Hayley, Buckley, Leo, Carbone, Salvatore, Kadariya, Dinesh, Van Tassell, Benjamin, Abbate, Antonio, Siddiqui, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799616/
http://dx.doi.org/10.1017/cts.2017.134
_version_ 1783460325852446720
author Canada, Justin M.
Billingsly, Hayley
Buckley, Leo
Carbone, Salvatore
Kadariya, Dinesh
Van Tassell, Benjamin
Abbate, Antonio
Siddiqui, Mohammad
author_facet Canada, Justin M.
Billingsly, Hayley
Buckley, Leo
Carbone, Salvatore
Kadariya, Dinesh
Van Tassell, Benjamin
Abbate, Antonio
Siddiqui, Mohammad
author_sort Canada, Justin M.
collection PubMed
description OBJECTIVES/SPECIFIC AIMS: Nonalcoholic fatty liver disease (NAFLD) affects 1 in 3 Americans and can exist in 2 histological subtypes: simple hepatic steatosis (SHS) and nonalcoholic steatohepatitis (NASH), a clinically aggressive variant. Fatigue is the most common complaint in patients with NAFLD but the etiology of fatigue is unknown. Thus, the goal of this study was to objectively evaluate fatigue via maximal cardiopulmonary exercise testing and identify determinants of exercise intolerance in NAFLD. METHODS/STUDY POPULATION: In total, 14 subjects with histologically confirmed NAFLD were prospectively enrolled. Subjects with cirrhosis or those with known history of heart failure (systolic or diastolic) were excluded. Fatigue was quantified via the Duke Activity Status Index (DASI) questionnaire. A symptom-limited treadmill cardiopulmonary exercise test was performed in all subjects to measure exercise time (ET) and peak oxygen consumption (peak VO(2)). Doppler-echocardiography was performed to measure systolic and diastolic function. RESULTS/ANTICIPATED RESULTS: The DASI score and ET was significantly reduced in patients with NASH (n=10) when compared to those with SHS [40.2 (IQR=24.2–50.7) vs. 58.2 (IQR=50.7–58.2), p=0.04]; [9.1 (IQR=6.4–12.2) vs. 13.1 (IQR=12.5–13.1) min, p=0.02, respectively] reflecting moderate fatigue and impaired overall exercise capacity. The ET was directly linked to peak VO(2) (R=+0.79, p<0.001), VO(2) at anaerobic threshold (R=+0.73, p=0.003), and inversely to ventilatory efficiency index (R=−0.785, p=0.001) suggesting impaired cardiorespiratory fitness in those with reduced ET. ET was also linked to several parameters of diastolic dysfunction including left atrial volume index (R=−0.798, p<0.001), and the ratio of early transmitral pulse-wave Doppler flow velocity (E) to early mitral annulus tissue Doppler velocity E’ (E/E’) (R=−0.608, p=0.036), suggesting a role of diastolic dysfunction in patients with NAFLD with exercise intolerance. DISCUSSION/SIGNIFICANCE OF IMPACT: Cardiac abnormalities drive cardiorespiratory fitness and exercise intolerance in patients with NAFLD. These findings are exaggerated in patients with NASH suggesting a link between disease severity in NAFLD, exercise intolerance and diastolic dysfunction.
format Online
Article
Text
id pubmed-6799616
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-67996162019-10-28 2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease Canada, Justin M. Billingsly, Hayley Buckley, Leo Carbone, Salvatore Kadariya, Dinesh Van Tassell, Benjamin Abbate, Antonio Siddiqui, Mohammad J Clin Transl Sci Clinical Trial OBJECTIVES/SPECIFIC AIMS: Nonalcoholic fatty liver disease (NAFLD) affects 1 in 3 Americans and can exist in 2 histological subtypes: simple hepatic steatosis (SHS) and nonalcoholic steatohepatitis (NASH), a clinically aggressive variant. Fatigue is the most common complaint in patients with NAFLD but the etiology of fatigue is unknown. Thus, the goal of this study was to objectively evaluate fatigue via maximal cardiopulmonary exercise testing and identify determinants of exercise intolerance in NAFLD. METHODS/STUDY POPULATION: In total, 14 subjects with histologically confirmed NAFLD were prospectively enrolled. Subjects with cirrhosis or those with known history of heart failure (systolic or diastolic) were excluded. Fatigue was quantified via the Duke Activity Status Index (DASI) questionnaire. A symptom-limited treadmill cardiopulmonary exercise test was performed in all subjects to measure exercise time (ET) and peak oxygen consumption (peak VO(2)). Doppler-echocardiography was performed to measure systolic and diastolic function. RESULTS/ANTICIPATED RESULTS: The DASI score and ET was significantly reduced in patients with NASH (n=10) when compared to those with SHS [40.2 (IQR=24.2–50.7) vs. 58.2 (IQR=50.7–58.2), p=0.04]; [9.1 (IQR=6.4–12.2) vs. 13.1 (IQR=12.5–13.1) min, p=0.02, respectively] reflecting moderate fatigue and impaired overall exercise capacity. The ET was directly linked to peak VO(2) (R=+0.79, p<0.001), VO(2) at anaerobic threshold (R=+0.73, p=0.003), and inversely to ventilatory efficiency index (R=−0.785, p=0.001) suggesting impaired cardiorespiratory fitness in those with reduced ET. ET was also linked to several parameters of diastolic dysfunction including left atrial volume index (R=−0.798, p<0.001), and the ratio of early transmitral pulse-wave Doppler flow velocity (E) to early mitral annulus tissue Doppler velocity E’ (E/E’) (R=−0.608, p=0.036), suggesting a role of diastolic dysfunction in patients with NAFLD with exercise intolerance. DISCUSSION/SIGNIFICANCE OF IMPACT: Cardiac abnormalities drive cardiorespiratory fitness and exercise intolerance in patients with NAFLD. These findings are exaggerated in patients with NASH suggesting a link between disease severity in NAFLD, exercise intolerance and diastolic dysfunction. Cambridge University Press 2018-05-10 /pmc/articles/PMC6799616/ http://dx.doi.org/10.1017/cts.2017.134 Text en © The Association for Clinical and Translational Science 2018 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Trial
Canada, Justin M.
Billingsly, Hayley
Buckley, Leo
Carbone, Salvatore
Kadariya, Dinesh
Van Tassell, Benjamin
Abbate, Antonio
Siddiqui, Mohammad
2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
title 2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
title_full 2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
title_fullStr 2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
title_full_unstemmed 2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
title_short 2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
title_sort 2390: cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
topic Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799616/
http://dx.doi.org/10.1017/cts.2017.134
work_keys_str_mv AT canadajustinm 2390cardiacabnormalitiesdriveexerciseintoleranceinpatientswithnonslcoholicfattyliverdisease
AT billingslyhayley 2390cardiacabnormalitiesdriveexerciseintoleranceinpatientswithnonslcoholicfattyliverdisease
AT buckleyleo 2390cardiacabnormalitiesdriveexerciseintoleranceinpatientswithnonslcoholicfattyliverdisease
AT carbonesalvatore 2390cardiacabnormalitiesdriveexerciseintoleranceinpatientswithnonslcoholicfattyliverdisease
AT kadariyadinesh 2390cardiacabnormalitiesdriveexerciseintoleranceinpatientswithnonslcoholicfattyliverdisease
AT vantassellbenjamin 2390cardiacabnormalitiesdriveexerciseintoleranceinpatientswithnonslcoholicfattyliverdisease
AT abbateantonio 2390cardiacabnormalitiesdriveexerciseintoleranceinpatientswithnonslcoholicfattyliverdisease
AT siddiquimohammad 2390cardiacabnormalitiesdriveexerciseintoleranceinpatientswithnonslcoholicfattyliverdisease